Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial.

RIGHT-2 Investigators; (2019) Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet, 393 (10175). pp. 1009-1020. ISSN 0140-6736 DOI: https://doi.org/10.1016/s0140-6736(19)30194-1

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/s0140-6736(19)30194-1

Abstract

Item Type Article
PubMed ID 30738649

Share

Download

Filename: Prehospital-transdermal-glyceryl-trinitrate.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar